N-glucuronidation of nicotine and cotinine by human liver microsomes and heterologously expressed UDP-glucuronosyltransferases
about
sameAs
Structure and Protein-Protein Interactions of Human UDP-GlucuronosyltransferasesNicotine metabolism in African Americans and European Americans: variation in glucuronidation by ethnicity and UGT2B10 haplotype.Role of CYP2A5 in the clearance of nicotine and cotinine: insights from studies on a Cyp2a5-null mouse modelLack of association between UGT1A7, UGT1A9, ARP, SPINK1 and CFTR gene polymorphisms and pancreatic cancer in Italian patients.UGT2B10 genotype influences nicotine glucuronidation, oxidation, and consumption.Heterologous expression of active human uridine diphosphate glucuronosyltransferase 1A3 in Chinese hamster lung cellsGlucuronidation genotypes and nicotine metabolic phenotypes: importance of functional UGT2B10 and UGT2B17 polymorphismsNicotine N-glucuronidation relative to N-oxidation and C-oxidation and UGT2B10 genotype in five ethnic/racial groups.Pathway analysis of smoking quantity in multiple GWAS identifies cholinergic and sensory pathways.The contribution of common genetic variation to nicotine and cotinine glucuronidation in multiple ethnic/racial populationsUGT1A and UGT2B genetic variation alters nicotine and nitrosamine glucuronidation in european and african american smokers.Genetic influences on individual differences in nicotine glucuronidationAssessing secondhand smoke using biological markersEnzymes and inhibitors in neonicotinoid insecticide metabolism.A model of in vitro UDP-glucuronosyltransferase inhibition by bile acids predicts possible metabolic disorders.Exposure to the carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers from 3 populations with different risks of lung cancer.The contribution of common UGT2B10 and CYP2A6 alleles to variation in nicotine glucuronidation among European AmericansTranscriptional regulation of human UDP-glucuronosyltransferase genes.Human UDP-Glucuronosyltransferase (UGT) 2B10: Validation of Cotinine as a Selective Probe Substrate, Inhibition by UGT Enzyme-Selective Inhibitors and Antidepressant and Antipsychotic Drugs, and Structural Determinants of Enzyme Inhibition.Pharmacokinetic Drug Interactions with Tobacco, Cannabinoids and Smoking Cessation Products.Biosynthesis of imipramine glucuronide and characterization of imipramine glucuronidation catalyzed by recombinant UGT1A4.Evaluation of glucuronide metabolite stability in dried blood spots.Effect of UGT2B10, UGT2B17, FMO3, and OCT2 genetic variation on nicotine and cotinine pharmacokinetics and smoking in African Americans.Variation in CYP2A6 Activity and Personalized Medicine.Longitudinal Influence of Pregnancy on Nicotine Metabolic Pathways.Influence of UGT2B10 genotype on urinary excretion of NNAL-N-glucuronide by African American smokers.Formation of N-glucuronides
P2860
Q28071266-68F6771C-1ACE-430D-82EA-9ACCA664D958Q33574895-6959337A-1D84-4FBD-9F57-CFBD254A7E4FQ33613568-9F6D0F09-B338-4F35-BB72-43009797E7EBQ33869132-5F3AE253-FDC0-4CF3-B71D-9F6683702892Q33903103-155B9037-1F10-4934-8E7C-181F8D978EA9Q34382432-3FE0537A-FFC2-4009-AA43-77F67987BCBBQ34390412-70428CB9-D6B0-4C55-81F1-7F5E88FB3EBBQ34434951-FC9E5316-0E8F-4B1E-B56D-D3784E84A5B8Q34507145-0F3ED817-33AD-4CB8-9523-F739787C4009Q34963910-A7A7ABE6-6BED-4086-BA3F-2329E1F35CF3Q34964392-6207BECB-168A-41B3-9FF7-262DFA8232C6Q35453743-D91B4A58-3873-4E8A-A8AA-431E076193DAQ36803952-D347D709-1C9B-4FD4-906B-DDA3AE151A18Q37231501-A7D97BB1-A965-4693-AA5A-2B29B72CE37AQ37305377-05749D19-518A-4936-816A-4AD8796D8CEEQ37426846-F5CD47F1-155E-4570-A4F7-8C3FB0D4AF95Q37573962-8C93AF76-1288-4612-B16D-EA66C5B87738Q38261875-681206E9-F60E-48AA-9839-9FCB8F0549A6Q38811693-5771482A-9C2D-4E7A-A99C-A5FC4204FC6DQ38815352-368ADA88-4F5A-4561-9744-B90B6E3D7969Q42037697-EED602EF-45C3-46E3-B0E7-2179DA38F5FCQ43465450-9DB09D60-339A-418C-A52A-B79D5E5113BBQ43585637-7CD63CC3-095D-4344-B11B-BB956B80468CQ47163198-34E56A1B-7EC7-4943-9DFA-79397C049C4AQ47572401-5241F0FB-F298-4D13-BAF6-00DF699FE432Q49820994-3223AF1D-65A4-4D66-98B6-DBD425D333E0Q50295358-04F6FB32-A6DB-4DB8-A032-EAAEADDD9090
P2860
N-glucuronidation of nicotine and cotinine by human liver microsomes and heterologously expressed UDP-glucuronosyltransferases
description
2003 nî lūn-bûn
@nan
2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
N-glucuronidation of nicotine ...... d UDP-glucuronosyltransferases
@ast
N-glucuronidation of nicotine ...... d UDP-glucuronosyltransferases
@en
N-glucuronidation of nicotine ...... d UDP-glucuronosyltransferases
@nl
type
label
N-glucuronidation of nicotine ...... d UDP-glucuronosyltransferases
@ast
N-glucuronidation of nicotine ...... d UDP-glucuronosyltransferases
@en
N-glucuronidation of nicotine ...... d UDP-glucuronosyltransferases
@nl
prefLabel
N-glucuronidation of nicotine ...... d UDP-glucuronosyltransferases
@ast
N-glucuronidation of nicotine ...... d UDP-glucuronosyltransferases
@en
N-glucuronidation of nicotine ...... d UDP-glucuronosyltransferases
@nl
P3181
P356
P1476
N-glucuronidation of nicotine ...... d UDP-glucuronosyltransferases
@en
P2093
Gwendolyn E Kuehl
Sharon E Murphy
P304
P3181
P356
10.1124/DMD.31.11.1361
P407
P577
2003-11-01T00:00:00Z